Overview

Mechanism of Action and Efficacy of Muraglitazar in Type 2 Diabetes

Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn more about how muraglitazar lowers blood sugar in people with type 2 diabetes. The safety of this treatment will also be studied.
Phase:
Phase 3
Details
Lead Sponsor:
Bristol-Myers Squibb
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Glycine